ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1607

The Association Between Thyroxin Substitution and Rheumatoid Arthritis; Results From the Swedish EIRA Study

Camilla Bengtsson1, Henrik Källberg1, Leonid Padyukov2 and Saedis Saevarsdottir3, 1Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, 2Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden, 3Rheumatology Unit, Dept. of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Anti-citrullinated protein/peptide antibodies (ACPA) and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Session Title: Epidemiology and Health Services Research II: Epidemiologic Risk Factors in the Development of Rheumatic Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: Hypothyroidism is usually of autoimmune nature, in areas with sufficient iodine, and leads to chronic substitution treatment with thyroxin. The disease shares some risk factors with ACPA-positive rheumatoid arthritis (RA), i.e. smoking and the PTPN22 risk allele, while different alleles of the HLA-DRB1 locus are associated with these diseases (RA: *01, *04 and *10 (shared epitope, SE); hypothyroidism: *03)1,2We asked whether thyroxin substitution was associated with RA overall, the ACPA-positive or ACPA-negative subset, and whether an interaction with SE alleles was present.

Methods: Data from the Swedish population-based EIRA (Epidemiological Investigation of Rheumatoid Arthritis) case-control study was analysed. In total, 1947 incident cases and 2246 randomly selected controls (matched on age, sex, residency), aged 18-70 years, participated in the study. Those who started treatment with thyroxin before the year of onset were compared those without treatment. Participants who reported a history of thyroid cancer (1 case and 1 control) were excluded from the analyses. We calculated odds ratios (OR) with 95% confidence intervals (CI) for RA overall and the ACPA-positive and ACPA-negative subsets, by means of unconditional logistic regression models. Adjustments for smoking and PTPN22 only marginally changed the results and were not retained in the final analyses. Interaction was evaluated by calculating the attributable proportion (AP) due to interaction and its 95% confidence interval (CI).

Results: The risk of RA among those with thyroxin substitution was doubled, compared with those without thyroxin substitution (OR=2.0, 95% CI 1.5–2.7). When divided by ACPA status, there were no major differences between these two subsets (ACPA-positive: OR=1.9, 95%CI 1.4–2.7); ACPA-negative: OR=2.2, 95%CI 1.5-3.1). The OR of ACPA-positive RA for the combination of thyroxin substitution and no SE was 1.4 (95% CI 0.7-3.0), compared with neither of these factors. The OR for the combination of no thyroxin substitution and SE was 5.7 (95% CI 4.6-6.9) and for the combination of thyroxin substitution and SE the OR was 12.0 (95% CI 7.1-20.4). Thus a strong interaction between SE and thyroxin substitution was observed (AP=0.5, 95% CI 0.2-0.8).

Conclusion: Thyroxin substitution, reflecting an underlying hypothyroidism, was associated with the risk of developing ACPA-positive and ACPA-negative  RA later in life. Thyroxin substitution also interacted with  the shared epitope in the development of ACPA-positive RA, indicating that in patients with hypothyroidism, the presence of the shared epitope alleles, provides an even higher risk of ACPA-positive RA. Our data suggest overlapping pathways in the development of two common autoimmune diseases.

  1. Tomer Y, Huber A: The etiology of autoimmune thyroid disease: a story of genes and environment. Journal of autoimmunity 2009, 32(3-4):231-239.
  2. Klareskog L, Catrina AI, Paget S: Rheumatoid arthritis. Lancet 2009, 373(9664):659-672.

Disclosure:

C. Bengtsson,
None;

H. Källberg,
None;

L. Padyukov,
None;

S. Saevarsdottir,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-association-between-thyroxin-substitution-and-rheumatoid-arthritis-results-from-the-swedish-eira-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences